Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis (MS).
Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS
The study, led by researchers at the University of Cambridge, is a step towards developing personalised treatments based on a patient’s own skin cells for diseases of the central nervous system (CNS).
In MS, the body’s own immune system attacks and damages myelin, the protective sheath around nerve fibres, causing disruption to messages sent around the brain and spinal cord. Symptoms are unpredictable and include problems with mobility and balance, pain, and severe fatigue.
Key immune cells involved in causing this damage are macrophages (literally ‘big eaters’), which ordinarily serve to attack and rid the body of unwanted intruders. A particular type of macrophage known as microglia are found throughout the brain and spinal cord – in progressive forms of MS, they attack the CNS, causing chronic inflammation and damage to nerve cells.
Recent advances have raised expectations that diseases of the CNS may be improved by the use of stem cell therapies. Stem cells are the body’s ‘master cells’, which can develop into almost any type of cell within the body. Previous work from the Cambridge team has shown that transplanting neural stem cells (NSCs) – stem cells that are part-way to developing into nerve cells – reduces inflammation and can help the injured CNS heal.
However, even if such a therapy could be developed, it would be hindered by the fact that such NSCs are sourced from embryos and therefore cannot be obtained in large enough quantities. Also, there is a risk that the body will see them as an alien invader, triggering an immune response to destroy them.
A possible solution to this problem would be the use of so-called ‘induced neural stem cells (iNSCs)’ – these cells can be generated by taking an adult’s skin cells and ‘re-programming’ them back to become neural stem cells. As these iNSCs would be the patient’s own, they are less likely to trigger an immune response.
Now, in research published in the journal Cell Stem Cell, researchers at the University of Cambridge have shown that iNSCs may be a viable option to repairing some of the damage caused by MS.
Using mice that had been manipulated to develop MS, the researchers discovered that chronic MS leads to significantly increased levels of succinate, a small metabolite that sends signals to macrophages and microglia, tricking them into causing inflammation, but only in cerebrospinal fluid, not in the peripheral blood.
Transplanting NSCs and iNSCs directly into the cerebrospinal fluid reduces the amount of succinate, reprogramming the macrophages and microglia – in essence, turning ‘bad’ immune cells ‘good’. This leads to a decrease in inflammation and subsequent secondary damage to the brain and spinal cord.
“Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS,” says Dr Stefano Pluchino, lead author of the study from the Department of Clinical Neurosciences at the University of Cambridge.
“This is particularly promising as these cells should be more readily obtainable than conventional neural stem cells and would not carry the risk of an adverse immune response.”
The research team was led by Dr Pluchino, together with Dr Christian Frezza from the MRC Cancer Unit at the University of Cambridge, and brought together researchers from several university departments.
Dr Luca Peruzzotti-Jametti, the first author of the study and a Wellcome Trust Research Training Fellow, says: “We made this discovery by bringing together researchers from diverse fields including regenerative medicine, cancer, mitochondrial biology, inflammation and stroke and cellular reprogramming. Without this multidisciplinary collaboration, many of these insights would not have been possible.”
The Latest on: Personalised stem cell treatment
via Google News
The Latest on: Personalised stem cell treatment
- Adicet data hints at early promise for 'gamma delta' cell therapyon May 27, 2022 at 6:15 am
Four of six lymphoma patients in a small trial went into remission, an early but encouraging sign for an emerging form of cellular immunotherapy.
- Tumor "Mutational Signatures" Predict Treatment Responseon May 27, 2022 at 3:06 am
Researchers have found that so-called “mutational signatures” – that reflect a collection of mutations found across the entire genome of a tumor – can predict the activity of various drugs applied to ...
- Anja Health Raises $4.5 Million to Offer Parents Technology to Freeze Umbilical Cord's Stem Cells for Future Disease Treatmenton May 26, 2022 at 4:32 pm
Umbilical cord blood banking platform Anja Health raised $4.5 million dollars in a seed round led by Seven Seven Six, a venture capital firm founded by Reddit co-founder Alexis Ohanian. Anja Health ...
- A new breast cancer marker that may help in personalized therapyon May 26, 2022 at 5:56 am
University of Southampton and it was found that these crown like structures could hinder their response to therapy. The findings of this study could potentially be used to improve personalised ...
- Breast cancer therapy success rates drop sharply for overweight peopleon May 25, 2022 at 1:16 pm
Being overweight can lead to several health issues and now a new study is revealing it can even hinder the treatment of breast cancer, according to a press release by the University of Southampton ...
- University of Southampton: Scientists discover a potential new marker to personalised therapy for breast canceron May 24, 2022 at 7:51 pm
A new study from the University of Southampton has discovered that ‘crown-like structures’ surrounding breast tumours in overweight and obese patients could hinder their response to therapy. The findi ...
- 'Crown-like structures' surrounding breast tumors could hinder treatment response, study findson May 24, 2022 at 7:39 am
A new study from the University of Southampton has discovered that 'crown-like structures' surrounding breast tumors in overweight and obese patients could hinder their response to therapy.
- A potential new marker for personalized breast cancer therapyon May 24, 2022 at 6:24 am
A new study from the University of Southampton has discovered that "crown-like structures" surrounding breast tumors in overweight and obese patients could hinder their response to therapy. The ...
- Scientists discover a potential new marker to personalized therapy for breast canceron May 24, 2022 at 4:44 am
A new study from the University of Southampton has discovered that ‘crown-like structures’ surrounding breast tumours in overweight and obese patients could hinder their response to therapy. The ...
- CAR T without the toxicity: Kelonia gets $50M for a new take on cell therapyon May 22, 2022 at 2:56 pm
Kelonia Therapeutics is developing cell therapies made by the in vivo engineering of a patient’s cells made possible by the targeted delivery of a genetic payload. The startup, newly out of stealth ...
via Bing News